Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL Meeting Abstract

  

Authors:	Coutre, S. E.; Furman, R. R.; Sharman, J. P.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; Ghia, P.; Eradat, H. A.; Ervin, T. J.; Lamanna, N.; Coiffier, B.; Pettitt, A.; Kim, Y.; Jahn, T. M.; O'Brien, S. M.; Hallek, M. J.
Abstract Title:	Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613203830
PROVIDER:	wos
DOI:	10.1200/jco.2014.32.15_suppl.7012
Notes:	Meeting Abstract: 7012 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/80870